Status:
COMPLETED
Correlation of the Clinical Behaviour of Renal Cell Carcinoma (RCC) After Debulking Nephrectomy With Tumor Gene Expression in Nephrectomy Specimens
Lead Sponsor:
National University Hospital, Singapore
Conditions:
Renal Cell Carcinoma
Eligibility:
All Genders
21+ years
Brief Summary
The objective of the study is to determine whether a specific immune microenvironment in the primary tumor is associated with a favorable clinical course after nephrectomy and in the absence of adjuva...
Detailed Description
Renal cell carcinoma (RCC) is a tumor with clinically apparent immunologic phenomena, such as response to immunotherapies (interferon, interleukin-2, immune cellular therapy etc), spontaneous regressi...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Advanced RCC who had a cytoreductive nephrectomy done.
- Patients did not receive specific anti-cancer systemic therapy after the nephrectomy, except after clinical disease progression.
- Tumor samples available.
Exclusion
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
End Date :
November 1 2013
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00718367
Start Date
March 1 2008
End Date
November 1 2013
Last Update
January 14 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National University Hospital
Singapore, Singapore